Halozyme Therapeutics shares owned by Stephens Investment Management Group
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Stephens Investment Management Group
from 13F filings
Historical chart of Stephens Investment Management Group investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Stephens Investment Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Stephens Investment Management Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $56M | 1.5M | 38.20 |
| 2023-06-30 | $48M | 1.3M | 36.07 |
| 2023-03-31 | $50M | 1.3M | 38.19 |
| 2022-12-31 | $74M | 1.3M | 56.98 |
| 2022-09-30 | $51M | 1.3M | 39.54 |
| 2022-06-30 | $57M | 1.3M | 44.00 |
| 2022-03-31 | $52M | 1.3M | 39.88 |
| 2021-12-31 | $51M | 1.3M | 40.21 |
| 2021-09-30 | $52M | 1.3M | 40.68 |
| 2021-06-30 | $50M | 1.1M | 45.41 |
| 2021-03-31 | $46M | 1.1M | 41.69 |
| 2020-12-31 | $42M | 974k | 42.71 |
| 2020-09-30 | $7.1M | 269k | 26.28 |
| 2020-06-30 | $4.7M | 174k | 26.81 |
More positions owned by Stephens Investment Management Group
View all positions for Stephens Investment Management Group